Skip to main content
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Font Resize
+A
A
-A
Contrast
عربي
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Home
Search Results
Containing any of the words
Only of the type
All
Cosmetics Warning
covid pages
Excellent establishments list
Scientific reports and statement
test
Vaccine Safety
Annual Report
calculators
Conference
Drug Membership
Drug Safety Labeling
Events
Hajj card
head of board
hpac-members
Laboratories
Marketed Products
Open Data
Periodic Safety
portables service
Regulations exceptions
sector committee
Sector Committee decisions
Speakers
Surveys
Awareness Article
Awareness Campaign
Circulars
Clinical Trial
Cosmetics standards Project
Drug Clinical Trial
Drug evaluation reports
Drug Log
Eservices
Event
Forms
HAPC Committee Decisions
Information List
International Standard
Lists
List Drugs Withdrawal
List of hospital that reported sides effects
List Registered Drugs
List Registered Pharmacies
List Shortage Drug
List Under registration Drugs / Under committee review
Medical devices studies
Medical Report
Message
News
New SFDA Drug Approvals
Podcasts
Reference repositories drugs
Risk Minimization Activity
Risk Minimization Activity - New
Rumours
Safety Alert
Scientific Magazines and articles
service providing facilities
Standard
Standards Projects For Medical Devices
Warehouse
Warnings
Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepatocellular Carcinoma (HCC) After Failure or Intolerance to Sorafenib. ReLive Study.
Drug Clinical Trial
(SG-2206-393-H-P) MiniMed™ 600 and 700 series insulin pump Battery Cap
Medical Report
DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer (DESTINY BTC01 - D781PC00001)
Drug Clinical Trial
A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia Without del(17p) or TP53 Mutation
Drug Clinical Trial
A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia Without del(17p) or TP53 Mutation
Drug Clinical Trial
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-I)
Drug Clinical Trial
An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-I)
Drug Clinical Trial
The SFDA Introduces Digital Tool to Advance Chemical Risk Assessment in Food Safety
News
SFDA Suspends Medical Device Imports from Manufacturer Following Quality Violations
News
Rules and Protocols are Applied in Food Facilities in Cases of Food Poisoning or Suspected Cases
Regulations
Pagination
First page
« First
Previous page
‹ Previous
…
الصفحة
185
الصفحة
186
الصفحة
187
الصفحة
188
Current page
189
الصفحة
190
الصفحة
191
الصفحة
192
الصفحة
193
…
Next page
Next ›
Last page
Last »